By: Benzinga
UPDATE: J.P. Morgan Initiates Coverage on Dynavax Technologies Corporation with Neutral Rating
In a report published Wednesday, J.P. Morgan & Co. initiated coverage on Dynavax Technologies Corporation (NASDAQ: DVAX ) with a Neutral rating. J.P. Morgan noted, “We are initiating coverage of Dynavax (DVAX) with a Neutral rating. Dynavax is a clinical stage biotechnology company with a focus on infectious and inflammatory
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here